ust

‘Alien: Isolation’ for Android Is Now a Free To Start Release Just Like iOS Letting Everyone Try Two Missions for Free

Earlier this year, Feral Interactive’s superb iOS version of Alien: Isolation (Free) was updated to change the game’s business model …




ust

Legendary Fighting Series ‘The King of Fighters’ Crosses Over into ‘Another Eden’ with the “Another Bout” Event that Kicks Off August 22nd

I did not have Another Eden, beloved mobile role-playing game, having a crossover event with The King of Fighters, legendary …




ust

‘SpongeBob: Bubble Pop’ Is a New Bust-a-Move-Like Coming to iOS and Android Through Tic Toc Games, Nickelodeon, and Netflix

Netflix recently announced more games coming to its service in the coming months, but an unannounced (as far as I’m …





ust

SwitchArcade Round-Up: Reviews Featuring ‘Bakeru’ & ‘Peglin’, Plus Highlights From Nintendo’s Blockbuster Sale

Hello gentle readers, and welcome to the SwitchArcade Round-Up for September 2nd, 2024. I think it’s a holiday today in …






ust

Spreadsheets have ruled Earth for too long—business must embrace the cloud

Cloud-based business management software (CRM, ERP) can revolutionise an SME.




ust

We’ve been missing a big part of game industry’s digital revolution

NPD “restatement” shows consistent spending growth as digital sales dominate.





ust

EA cracks down on modders selling their custom Sims 4 content

But publisher leaves lucrative loophole for "early access" Patreon subscriptions.




ust

Voters Just Said No to Drugs: Why legalization lost at the ballot box...


Voters Just Said No to Drugs: Why legalization lost at the ballot box...


(Third column, 4th story, link)


Drudge Report Feed needs your support!   Become a Patron




ust

ZOE WILLIAMS: Billionaires don't just think they're better than rest of us -- they hate us...


ZOE WILLIAMS: Billionaires don't just think they're better than rest of us -- they hate us...


(Second column, 6th story, link)





ust

America’s Battery Plant Boom Isn’t Going Bust – Factory Construction Is on Track

A new battery plant under construction in South Carolina will supply BMW factories.




ust

Archbishop of Canterbury Justin Welby resigns over sex abuse scandal

Archbishop of Canterbury Justin Welby has resigned over accusations that he failed to report physical and sexual abuse to the police.




ust

An underwater war story: See ships sunk by Hitler’s U-boats just off Bell Island

Go beneath the waves and back in time to explore the incredible story of the German attack on Bell Island. In 1942, four merchant ships were sunk by Hitler’s U-boats, coming to a final rest on the ocean floor. Now, we’ve teamed up with historians and divers to take you on an underwater tour of the shipwrecks.




ust

Gus the penguin makes mysterious solo trip to popular Australian beach

An emperor penguin found malnourished far from its Antarctic home on the Australian south coast is being cared for by a wildlife expert, a government department said Monday.




ust

Time limits for trials were meant to speed up justice. They've also halted hundreds of criminal cases

Supporters say the Supreme Court of Canada's so-called Jordan ruling in 2016 has sped up proceedings and strengthened Charter rights for prompt justice. But some victims say the time limits for trials work in criminals' favour and cases continue to collapse because those limits are breached. 



  • News/Canada/British Columbia

ust

Things just got personal again

Ten years after the iPhone dug its grave, the personal computer is rising like a phoenix.




ust

Australia’s best bacon awarded

GOT a hankering for bacon? The best bacon from across Australia has been judged at Australian Bacon Week.




ust

Wanderers just fall short

WE’RE obviously very disappointed. Our whole season led to this moment and unfortunately we just came up short. But it doesn’t take away from what has been a great season.




ust

Jesse James represents Australia

Jesse James has a legendary moniker, and now the martial arts black belt is set to make his own name known on the world stage, representing Australia.




ust

FOPE spots potential opportunities for Indian cos in Australia & ECTA seen to propel easy market access

The Federation of Pharmaceutical Entrepreneurs (FOPE) has identified potential opportunities for Indian pharmaceutical companies to expand in Australia. Further, the India─Australia Economic Cooperation and Trade




ust

DoP releases operational guidelines for Strengthening of Medical Device Industry scheme

The Department of Pharmaceuticals (DoP) has released the operational guidelines for the newly announced central sector scheme for Strengthening of Medical Device Industry (SMDI), aiming at providing




ust

Indian healthcare industry to invest further in computational infrastructure for data integration in patient care

The Indian healthcare industry is looking to invest further in computational infrastructure as data integration frameworks and regulatory compliance are pivotal to ensure intelligent clinical support




ust

Industry hails DoP's new scheme for strengthening of medical devices industry

The centrally sponsored scheme for strengthening of medical devices industry (SMDI), launched by the Central government last week, was widely welcomed by the medical devices industry in the country.




ust

Q&A: Bringing sustainability into the medical industry

Brightmark CEO Bob Powell discusses Plastics Renewal technology and how to bring sustainability into the medical industry.




ust

How are contract manufacturers driving sustainability?

Nick Guerin, CSP, director of environmental, health & safety at Tessy Plastics highlights how contract manufacturers are driving sustainability in the medical plastics industry.




ust

The Law Must Respond When Science Changes

What was once fair under the law may become unfair when science changes. The law must react to uphold due process




ust

Another IRA Surprise: Part B Coinsurance Inflation Adjustments Are Increasing Patient Costs (rerun)

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors.

The article below highlights an underappreciated consequence of the Inflation Reduction Act’s inflation rebates for Medicare Part B drugs. Last night, I posted an updated analysis showing that the volatility in seniors' coinsurance rates continues. For the fourther quarter of 2024, coinsurance rates for 51 drugs increased, while rates for only 19 drugs decreased. What's more, rates for 17 drugs returned to their original 20% level. Click here to see our original post from May 2024.



Contrary to what you may have heard, the Inflation Reduction Act’s (IRA) inflation rebates for Medicare Part B drugs do not always save money for seniors.

As we document below, a growing share of Part B drugs have inflation-adjusted coinsurance rates that have been increasing, not declining. In many cases, the coinsurance rate declines only briefly before rebounding back to the standard 20% rate. What’s more, these fluctuations have triggered huge jumps in patients’ out-of-pocket obligations for some drugs—even when a drug’s costs were falling.

Chalk off these coinsurance surprises to yet another unintended consequence of the IRA. Seniors who are expecting to see costs drop may find they are instead being taken for a rollercoaster ride.
Read more »
       




ust

Sequestration Has Less Impact on FDA? Just Not True

“The Hill” newspaper recently reported that: “a survey of federal budgets devoted to developing and enforcing regulations found that many agencies will spend more in 2013 and 2014 than in previous years, indicating that the writing and enforcing of new regulations is largely unimpeded by the massive cuts, known as sequestration.” That certainly sounds authoritative…until you look at the analysis. In fact, the report’s authors appear to know nothing about the federal budget and have used inherently unreliable data in calculating FY 13 and FY 14 spending levels. One can only hope that the authors—allegedly academic experts--know more about regulatory policy than they do about federal budgets.




ust

FDA approves biosimilars: ustekinumab Otulfi and eculizumab Epysqli

<p>The US Food and Drug Administration (FDA) granted approval for two&nbsp;biosimilars, Formycon’s FYB202/Otulfi (ustekinumab-aauz) and Samsung Bioepis’ Soliris biosimilar, Epysqli (eculizumab-aagh), on 27 September and 22 July 2024, respectively. FYB202/Otulfi, a biosimilar referencing&nbsp;Johnson &amp; Johnson’s Stelara, while Epysqli is a biosimilar referencing Alexion’s Soliris.</p>




ust

EC approval for three ustekinumab biosimilar: Eksunbi, Fymskina, Otulfi

<p>The European Commission (EC) granted marketing authorization for<b>&nbsp;</b>three ustekinumab biosimilars<b>:&nbsp;</b>Samsung Bioepis’ Eksunbi on 12 September 2024; Formycon’s Fymskina, and Fresenius Kabi’s&nbsp;Otulfi on 25 September 2024.</p>




ust

UK universities and NHS trusts that flout the rules on clinical trials identified in report to Parliament

An AllTrials report for the House of Commons Science and Technology Select Committee this week has found that 33 NHS trust sponsors and six UK universities are reporting none of their clinical trial results, while others have gone from 0% to 100% following an announcement from the Select Committee in January that universities and NHS […]




ust

Chronic itch is miserable. Scientists are just scratching the surface

Journalist Annie Lowrey has a rare disease that causes a near-constant itch that doesn't respond to most treatments. She likens the itchiness to a car alarm: "You can't stop thinking about it."




ust

Pregnant and Empowered: Why Trust is the Latest Form of Member Engagement

Three ways health plans can engage, connect with, and delight their pregnant members to nurture goodwill, earn long-term trust, and foster loyal relationships that last.

The post Pregnant and Empowered: Why Trust is the Latest Form of Member Engagement appeared first on MedCity News.




ust

The Trust-Building Playbook: 5 Tips Every Digital Health Marketer Needs to Know

Building trust while simultaneously building products, selling, recruiting, and fundraising can feel impossible. But it’s required whether you have the time or not, and it doesn’t stop no matter how big you grow.

The post The Trust-Building Playbook: 5 Tips Every Digital Health Marketer Needs to Know appeared first on MedCity News.




ust

How Can Healthcare Organizations Earn Trust with Marginalized Communities?

Access to care isn’t enough. Healthcare organizations need to build trust in order to reach underserved communities, experts said on a recent panel.

The post How Can Healthcare Organizations Earn Trust with Marginalized Communities? appeared first on MedCity News.




ust

Extending the Patentable Life of 3D Printers: A Lesson From the Pharmaceutical Industry

Modern innovation typically occurs one step-improvement at a time. Some clients initially question whether their new application of an existing technology is patentable. Usually, the answer is ‘yes.’ Under U.S. law (and most other jurisdictions), an innovation to an existing technology is patentable so long as at least one claim limitation is novel and non-obvious....… Continue Reading




ust

J&J must pay $19m to man who says its talc caused his cancer, jury finds

Johnson & Johnson must pay US$15 million (S$19.6 million) to a Connecticut man who alleges that he developed mesothelioma, a rare form of cancer, as a result of using the company's talc powder for decades, a jury found on Tuesday (Oct 15). Plaintiff Evan Plotkin sued the company in 2021 soon after his diagnosis, saying he was sickened by inhaling J&J's baby powder. The jury in Fairfield County, Connecticut Superior Court also found that the company should pay additional punitive damages, which will be determined later by the judge overseeing the case. "Evan Plotkin and his trial team are thrilled that a jury once again decided to hold Johnson & Johnson accountable for their marketing and sale of a baby powder product that they knew contained asbestos," Ben Braly, a lawyer for Plotkin, said in an email. Erik Haas, J&J's worldwide vice president of litigation, said in a statement that the company would appeal "erroneous" rulings by the trial judge that kept the jury from hearing critical facts about the case.




ust

'I just want closure': Qoo10 vendors, customers accept they will likely not get money back

SINGAPORE - When an online retailer began selling his products on e-commerce platform Qoo10 in August 2023, he did not bat an eyelid when it took 30 to 45 days for the platform to disburse his first payout, compared with about three to seven days for other e-commerce sites he was using. But nearly a year later in July, payments owed to his business by Qoo10 had ballooned to about $1.6 million, as the platform’s payment delays exceeded two months and disbursements began trickling in, in smaller amounts. The Singaporean, who wanted to be known only as Mr T and did not wish to divulge what he sold, pulled the plug on his Qoo10 shop this year in the middle of July, and filed a civil claim with the courts. He obtained a default judgment in October for Qoo10 to pay him what he is owed, after the e-commerce site failed to serve a notice of intention to contest or not contest the claim. Mr T, who added that he had borrowed nearly $1 million from banks, friends and relatives to pay his suppliers, said: “I am not holding out hope that I will get much, or any, of my money back from Qoo10... By this point, I just want closure because it’s been so stressful.”




ust

Fugitive lawyer Charles Yeo in UK custody, awaiting extradition hearing

Fugitive lawyer Charles Yeo, who is in custody in the UK, is currently awaiting an extradition hearing, reported CNA on Tuesday (Nov 12).  A court date for the extradition hearing has not been determined, but Yeo is set to attend a bail hearing on Friday, according to the report. In an Instagram post on Nov 1, the former chairman of the Reform Party said the Singapore government had made a formal request for his extradition. In his post, Yeo also said that he will be presenting himself, together with his legal team, at Westminster Magistrates Court on Nov 11. Yeo left Singapore in July 2022 after being charged earlier that year with multiple offences relating to harassment and wounding the religious feelings of Christians in several social media posts. In August 2022, a warrant of arrest was issued against him for breaching the conditions for overseas travel while on bail.  He was allowed to travel to Vietnam for work, but failed to return to Singapore and claimed he was seeking political asylum in the UK. 




ust

218043: Ice may have cracked, but Sharifs stil distrust in Zardari

Shahbaz noted that Zardari appealed to the PML-N to avoid mentioning allegations that former Chief Justice Hamid Dogar had arranged preferential treatment for his daughter's school admission




ust

Benazir spoke of terror camps, bid to oust her




ust

Data | Andheri East: Not a NOTA notable, just a blip amid falling vote shares

NOTA continues to be salient in Naxalite areas, but its share has fallen in recent elections




ust

Local Start-ups Hold the Key to Transforming Africa's Seed Industry

"The seed industry in sub-Saharan Africa is informal in nature, with approximately 80% of farmers saving and replanting seeds from year to year. This gives them security of access. But improved varieties — including high-yielding and hybrid crops — will increase productivity and income. To get these seeds into the hands of farmers, a better marketing and distribution system is needed. Local small and medium-sized seed enterprises have a comparative advantage in reaching this underserved market due to their size and market reach."




ust

AI Needs to Be Both Trusted and Trustworthy

Sensors, actuators, and IoT devices will enable AI to interact with the physical plane on a massive scale. The question is, how does one build trust in its actions?